- Home
- CDXS vs BNY Comparison
CDXS vs BNY Comparison
Compare CDXS & BNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- BNY
- Stock Information
- Founded
- CDXS 2002
- BNY 2001
- Country
- CDXS United States
- BNY United States
- Employees
- CDXS N/A
- BNY N/A
- Industry
- CDXS Major Chemicals
- BNY Trusts Except Educational Religious and Charitable
- Sector
- CDXS Industrials
- BNY Finance
- Exchange
- CDXS Nasdaq
- BNY Nasdaq
- Market Cap
- CDXS 216.6M
- BNY 247.3M
- IPO Year
- CDXS 2010
- BNY N/A
- Fundamental
- Price
- CDXS $2.12
- BNY $10.18
- Analyst Decision
- CDXS Buy
- BNY
- Analyst Count
- CDXS 2
- BNY 0
- Target Price
- CDXS $11.00
- BNY N/A
- AVG Volume (30 Days)
- CDXS 656.9K
- BNY 52.7K
- Earning Date
- CDXS 11-06-2025
- BNY 01-01-0001
- Dividend Yield
- CDXS N/A
- BNY 3.93%
- EPS Growth
- CDXS N/A
- BNY N/A
- EPS
- CDXS N/A
- BNY N/A
- Revenue
- CDXS $57,164,000.00
- BNY N/A
- Revenue This Year
- CDXS $12.88
- BNY N/A
- Revenue Next Year
- CDXS $21.64
- BNY N/A
- P/E Ratio
- CDXS N/A
- BNY N/A
- Revenue Growth
- CDXS N/A
- BNY N/A
- 52 Week Low
- CDXS $1.90
- BNY $8.60
- 52 Week High
- CDXS $6.08
- BNY $10.80
- Technical
- Relative Strength Index (RSI)
- CDXS 31.30
- BNY 47.72
- Support Level
- CDXS $2.52
- BNY $10.12
- Resistance Level
- CDXS $2.80
- BNY $10.32
- Average True Range (ATR)
- CDXS 0.14
- BNY 0.09
- MACD
- CDXS -0.06
- BNY -0.03
- Stochastic Oscillator
- CDXS 1.54
- BNY 20.69
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About BNY BlackRock New York Municipal Income Trust
Blackrock NY Municipal Income Tr investment objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes and New York State and New York City personal income taxes as is consistent with its investment policies and prudent investment management.